Alkermes plc. Property, Plant and Equipment, Gross
Alkermes plc. (ALKS) had Property, Plant and Equipment, Gross of $500.63 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-07-28
- 2026-06-30: Property, Plant and Equipment, Gross $500.63M.
- 2026-03-31: Property, Plant and Equipment, Gross $495.81M.
- 2025-12-31: Property, Plant and Equipment, Gross $488.73M.
- 2025-09-30: Property, Plant and Equipment, Gross $510.58M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $500.63M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $495.81M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $488.73M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $510.58M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $504.32M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $494.33M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $480.58M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $474.49M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $464.92M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $463.06M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $457.10M 10-K · filed 2025-02-12 | |
| 2023-09-30 | $790.21M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $777.43M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $764.67M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $437.68M 10-K · filed 2024-02-21 | $759.02M 10-K · filed 2023-02-16 |
| 2022-09-30 | $751.74M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $752.71M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $741.99M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $736.62M 10-K · filed 2023-02-16 | |
| 2021-09-30 | $724.83M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $718.79M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $712.21M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $706.15M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $704.04M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $700.10M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $690.40M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $679.21M 10-K · filed 2021-02-11 | |
| 2019-09-30 | $648.31M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $622.96M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $607.08M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $587.46M 10-K · filed 2020-02-13 | |
| 2018-09-30 | $571.64M 10-Q · filed 2018-10-23 | |
| 2018-06-30 | $555.37M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $539.02M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $524.79M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $502.90M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $489.43M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $479.19M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $470.72M 10-K · filed 2018-02-16 | |
| 2016-09-30 | $460.48M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $448.24M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $438.56M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $429.57M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $409.98M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $400.48M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $446.13M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $435.90M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $445.16M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $437.33M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $432.60M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $428.14M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $417.99M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $414.29M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $410.73M 10-KT · filed 2014-02-27 | |
| 2012-12-31 | $406.55M 10-Q · filed 2013-01-31 | |
| 2012-09-30 | $402.22M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $398.13M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $416.30M 10-K · filed 2013-05-23 | |
| 2011-03-31 | $186.73M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |